XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.1
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities (Tables)
12 Months Ended
Dec. 31, 2020
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities  
Schedule of marketable investment securities, restricted cash and cash equivalents, and other investment securities

As of December 31,

 

2020

    

2019

 

(In thousands)

Marketable investment securities:

Current marketable investment securities

$

132,593

$

Restricted marketable investment securities (1)

390

Total marketable investment securities

132,593

390

Restricted cash and cash equivalents (1)

58,323

60,677

Other investment securities:

Other investment securities

97,306

106,874

Total other investment securities

97,306

106,874

Total marketable investment securities, restricted cash and cash equivalents, and other investment securities

$

288,222

$

167,941

(1)Restricted marketable investment securities and restricted cash and cash equivalents are included in “Restricted cash, cash equivalents and marketable investment securities” on our Consolidated Balance Sheets.
Schedule of investments measured at fair value on a recurring basis

As of December 31,

2020

2019

 

Total

    

Level 1

    

Level 2

    

Level 3

    

Total

    

Level 1

    

Level 2

    

Level 3

(In thousands)

Cash equivalents (including restricted)

$

1,278,971

$

172,025

$

1,106,946

$

$

60,677

$

60,677

$

$

Debt securities (including restricted):

U.S. Treasury and agency securities

$

22,476

$

22,476

$

$

$

390

$

390

$

$

Commercial paper

101,959

101,959

Corporate securities

8,068

8,068

Other

90

90

Total

$

132,593

$

22,476

$

110,117

$

$

390

$

390

$

$

Gains and Losses on Sales and Changes in Carrying Amounts of Investments

For the Years Ended December 31,

Other, net:

    

2020

    

2019

    

2018

 

 

(In thousands)

Marketable investment securities - realized and unrealized gains (losses)

$

$

3,119

$

5,313

Costs related to early redemption of debt

(3,261)

Gain (loss) on sale of subsidiary

7,004

Equity in earnings (losses) of affiliates

653

3,514

(2,110)

Other

1,033

976

2,048

Total

$

1,686

$

7,609

$

8,994